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Binding of NUFIP2 to Roquin promotes recognition
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The ubiquitously expressed RNA-binding proteins Roquin-1 and Roquin-2 are essential for
appropriate immune cell function and postnatal survival of mice. Roquin proteins repress
target mRNAs by recognizing secondary structures in their 3′-UTRs and by inducing mRNA
decay. However, it is unknown if other cellular proteins contribute to target control. To
identify cofactors of Roquin, we used RNA interference to screen ~1500 genes involved in
RNA-binding or mRNA degradation, and identiﬁed NUFIP2 as a cofactor of Roquin-induced
mRNA decay. NUFIP2 binds directly and with high afﬁnity to Roquin, which stabilizes NUFIP2
in cells. Post-transcriptional repression of human ICOS by endogenous Roquin proteins
requires two neighboring non-canonical stem-loops in the ICOS 3′-UTR. This unconventional
cis-element as well as another tandem loop known to confer Roquin-mediated regulation of
the Ox40 3′-UTR, are bound cooperatively by Roquin and NUFIP2. NUFIP2 therefore emerges
as a cofactor that contributes to mRNA target recognition by Roquin.
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The RNA-binding proteins (RBPs) Roquin-1 and Roquin-2recognize speciﬁc stem-loop structures in the 3′-untrans-lated regions (3′-UTR) of target mRNAs through their
ROQ domain1–4. Binding typically results in post-transcriptional
repression of target-mRNA expression through 5′ mRNA
degradation5. However, the importance and cooperation of other
RBPs in this function is still elusive. Drosophila, mouse and
human ROQUIN-1 and ROQUIN-2 were described to interact
with the CCR4-CAF1-NOT de-adenylation complex5–7. Dead-
enylation is then coupled to mRNA decapping, followed by 5′ to
3′-directed mRNA decay5. It is likely that Roquin induces post-
transcriptional repression as part of higher-order messenger
ribonucleoprotein particles (mRNPs) that can be regulated in cell-
type speciﬁc and dynamic ways and differ among the cellular
target mRNAs. Especially on long and complex 3′-UTRs, Roquin
may interact, synergize or interfere with other post-
transcriptional regulators that work in a redundant, cooperative
or antagonistic way. Indeed, the 3′ terminal 260 nucleotides (nts)
of the TNF 3′-UTR were sufﬁcient to mediate repression by
Roquin-1 and the endonuclease Regnase-1 in a cooperative
manner8, while other target mRNAs may be repressed by each
trans-acting factor individually9. Except for Regnase-1, crucial
cofactors and collaborating RBPs of Roquin are still unknown.
The two Roquin paralogs are expressed ubiquitously and are
also required in cells outside of the adaptive immune system, since
mice with systemic deletion of Roquin-1 or Roquin-2 die
postnatally10,11. Both proteins serve redundant functions in
T cells11 by regulating T-cell activation and T-helper cell
differentiation8,11–13. The critical importance of Roquin-mediated
gene regulation in T cells is underscored by its cleavage by MALT1
downstream of T-cell receptor signaling, which affects multiple
target mRNAs with T-cell-speciﬁc expression and function8,12,14.
Accordingly, the inducible T-cell co-stimulatory receptor ICOS,
whose ~2000 nucleotide-long 3′-UTR harbors cis-elements for
several trans-acting factors8,15–17, was the ﬁrst identiﬁed mRNA
target of Roquin-113. In sanroque mice, a point mutation in the
ROQ domain of Roquin-1 impairs Roquin function and causes
derepression of ICOS already in naive T cells13. It has been pro-
posed that inappropriate ICOS expression can explain the devel-
opment of the severe autoimmunity of sanroque mice18 although
additional deletion of ICOS did not sufﬁce to rescue auto-
immunity19. Nevertheless, ICOS is important for the expansion
and survival of regulatory T cells (Tregs) and effector memory
T cells20. ICOS signals are also required for the differentiation of
follicular helper T cells (Tfh) and germinal center B cells21,22. ICOS
stimulation induces PI3K activity and Foxo-1 inactivation23 and
was shown to recruit activated CD4+ T cells into the follicle24 and
to be required for the maintenance of a germinal center response25.
Finally, patients with loss-of-function mutations in ICOS are
immunodeﬁcient26. The principles of post-transcriptional regula-
tion of ICOS are therefore of considerable interest and the
underlying molecular mechanisms may similarly control other,
perhaps even unknown mRNA targets of Roquin proteins.
In this study, we identify NUFIP2 as an important cofactor of
Roquin-mediated post-transcriptional gene regulation of ICOS.
Investigating its functional contribution, we demonstrate that
NUFIP2 engages in a direct, high-afﬁnity interaction with
Roquin-1 that enables cooperative binding of this complex to
tandem stem-loops in the ICOS and Ox40 3′-UTRs. Our data
indicate cofactor-dependent target speciﬁcity in Roquin-mediated
post-transcriptional gene regulation.
Results
Targeted siRNA screening to identify cofactors of Roquin. To
search for potential cofactors of Roquin-mediated post-
transcriptional gene regulation, we performed a targeted siRNA
screen. In a HeLa reporter cell line stably co-expressing ICOS and
an inducible Roquin-1-P2A-mCherry open reading frame
(Fig. 1a, b), we observed strong downregulation of ICOS protein
levels after doxycycline-induced Roquin-1 and mCherry expres-
sion (Fig. 1b). siRNA-mediated depletion of Roquin resulted in
derepression of ICOS (Fig. 1c, d). The assay was both robust and
reproducible, as indicated by a Z′ factor of 0.7 (Fig. 1d), which
reﬂects the suitability of a given assay for high-throughput
screening27. In the screen, each gene was targeted by a pool of
four individual siRNAs, and multiplexed ﬂow cytometry was
employed during data acquisition (Supplementary Fig. 1a, b). In
total, we screened 1495 siRNAs speciﬁcally targeting genes
encoding proteins associated with four ontology terms: “RNA-
binding proteins”28, “P body/stress-granule-related proteins”29,
“deadenylation-dependent mRNA decay”, and “decapping-
dependent mRNA decay”30–32 (Supplementary Data 1, Fig. 1e).
EDC4 and CNOT1, two effectors of mRNA deadenylation and
decapping that interact with Roquin6,15, scored positively and
thereby validated our screen. Yet, REGNASE-1, an endo-
ribonuclease that cooperates with Roquin-1 in the repression of a
reporter containing the most 3′ located 260 nts of the TNF 3′-
UTR (termed CDE260)8, was not identiﬁed in our screen. Inves-
tigating why REGNASE-1 (encoded by the ZC3H12A gene) was
not a hit in this screen, we found that the regulation of the ICOS
3′-UTR by Roquin-1 did not depend on Regnase-1, in contrast to
the CDE260 cis-element of the TNF 3′-UTR (Supplementary
Fig. 1c, d)8. Speciﬁcally, Roquin-1 overexpression downregulated
the ICOS reporter to a similar extent in Regnase-1-deﬁcient
(Zc3h12a−/−) (Supplementary Fig. 1f) and Roquin-deﬁcient
(Rc3h1/2−/−) mouse embryonic ﬁbroblast (MEF) cells (Supple-
mentary Fig. 1e). Moreover, the ICOS 3′-UTR was similarly
regulated by overexpression of Regnase-1 in Roquin-deﬁcient and
Regnase-1-deﬁcient cells (Supplementary Fig. 1e, f). Together,
these results show that the screen identiﬁed known genes
involved in Roquin-mediated ICOS regulation as well as new
candidates.
Validation of NUFIP2 as a cofactor of Roquin. We validated
top scoring candidates in the siRNA screen by “deconvoluting”
the siRNA pools and testing each individual siRNA. Candidates
such as STAUFEN (STAU1) did not pass this validation step
(Supplementary Data 1), as only one siRNA reversed ICOS
repression (Supplementary Fig. 2a, b), despite the fact that all four
siRNAs efﬁciently depleted STAU1 mRNA (Supplementary
Fig. 2c). In contrast, these analyses conﬁrmed CNOT1 as a
positive control and validated NUFIP2 as a cofactor of Roquin-1-
mediated ICOS regulation. For these two targets, multiple siRNAs
from the original pool decreased CNOT1 or NUFIP2 target
mRNA without diminishing Roquin-1-P2A-mCherry expression
and caused derepression of ICOS (Fig. 2a–c). Our CNOT1 results
conﬁrm the recently demonstrated impairment of Dm Roquin to
induce reporter mRNA degradation in Drosophila cells with
CNOT1 depletion5. Strikingly, NUFIP2 was among the strongest
hits in this screen, and its knockdown derepressed ICOS more
effectively than that of CNOT1 (Fig. 3a). Both siRNA pools efﬁ-
ciently decreased target gene expression on mRNA and protein
levels (Fig. 3b, c). We further validated NUFIP2 as a cofactor of
Roquin through rescuing the effect of the siRNA by over-
expressing an siRNA#2-resistant NUFIP2 cDNA (Supplementary
Fig. 2d). GFP-NUFIP2- or GFP-overexpressing HeLa reporter
cells (Fig. 3d) were transfected with siRNA#2, which only targets
the endogenous protein, or siRNA#4, which targets both endo-
genous and ectopically expressed NUFIP2 (Supplementary
Fig. 2d). ICOS surface expression upon doxycycline-induced
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Roquin-1 overexpression was analyzed in gates that contained
low (GFPlo), medium (GFPmed), or high (GFPhi) GFP expression
(Fig. 3e, f). Importantly, in siRNA#2-transfected cells, ICOS was
signiﬁcantly downregulated by increasing expression of siRNA#2-
resistant GFP-NUFIP2 in GFPmed and GFPhi cells (Fig. 3f, upper
graph). Cells with comparable GFP-NUFIP2 expression were not
observed when GFP-NUFIP2 expression was combined with
transfections of siRNA#4 that effectively reduced the ectopic
NUFIP2 expression (Fig. 3e). In the remaining GFP-expressing
cells within the GFPmed gate the ICOS repression was also not
rescued (Fig. 3f, lower graph). Of note, the transduction of cells
with GFP did not change ICOS expression (Fig. 3f upper and
lower graph). Together these experiments identiﬁed and validated
NUFIP2 as a cofactor of Roquin-mediated ICOS repression.
We next asked how ICOS was regulated by NUFIP2 and
whether this regulation required Roquin proteins. To do so we
combined the siRNA against NUFIP2 with those against RC3H1
and RC3H2 to target both ROQUIN-1- and ROQUIN-2-
encoding mRNAs in HeLa cells that stably expressed ICOS
mRNA (Fig. 3g, h). The combinations of all three siRNAs equally
reduced NUFIP2 and ROQUIN-encoding mRNAs compared to
transfections that targeted the factors individually (Fig. 3g).
Treating these cells with actinomycin D and measuring ICOS
mRNA abundance by quantitative RT-PCR over time revealed a
half-life of ICOS mRNA of 158 min in control siRNA-treated
cells, which increased to 232min when NUFIP2 was knocked
down. Importantly, the knockdown of ROQUIN- or ROQUIN-
and NUFIP2-encoding mRNAs similarly stabilized the ICOS
mRNA to a half-life of 345 or 360min, respectively (Fig. 3h). This
indicates that NUFIP2 cooperates with ROQUIN to induce ICOS
mRNA decay, as the effectiveness of NUFIP2 to induce
degradation of ICOS mRNA depended on the presence of
ROQUIN proteins (Fig. 3h).
Molecular determinants of NUFIP2 function. For the detection
of NUFIP2, we established two different monoclonal antibodies,
23G8 and 14G9, for western blotting and immunoprecipitation
(Supplementary Fig. 2e, f) or intracellular staining and ﬂow
cytometry, respectively (Supplementary Fig. 2g, h).
Roquin function is associated with its localization in RNA
granule-like structures. In the absence of cell stress, the protein is
enriched in P bodies15. In response to arsenite-induced oxidative
stress, Roquin relocalizes to stress granules15,33,34. As a
biochemical assay that mimics aggregation of proteins in
granule-like structures, the chemical biotinylated isoxazole (b-
isox) precipitates constituents of stress granules like FMRP,
FXR1P and FXR2P from cell lysates35. Since NUFIP2 has been
described to interact with FMRP in cells36, we investigated
aggregation of Roquin, Nuﬁp2, and Fmrp by incubating MEF cell
lysates with increasing concentrations of b-isox. Treatment and
subsequent centrifugation localized the Fmrp protein to the pellet,
depleting it from the supernatant at all b-isox concentrations
(Fig. 4a). Nuﬁp2 precipitated at 1 µM b-isox, but unlike Fmrp was
not depleted from the supernatant. The Roquin proteins also
partially precipitated, but only in response to the high
concentrations of b-isox (Fig. 4a). Consistent with the presence
of low complexity regions (LCR) in the carboxy-terminus of
Roquin, the amino-terminal fragment of Roquin, which results
from MALT1 paracaspase-mediated cleavage12,14, did not pre-
cipitate as well (Fig. 4a). These experiments suggest that in
ﬁbroblast extracts only a subset of the Nuﬁp2 protein is associated
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Fig. 1 A targeted siRNA screen to identify cofactors of Roquin-mediated post-transcriptional gene regulation. a Immunoblot analysis of Roquin-1, Roquin-2,
and α-Tubulin expression or b ﬂow cytometry of ICOS and mCherry expression in HeLa reporter cells containing cassettes for stable ICOS and doxycycline-
inducible Roquin-1-P2A-mCherry overexpression. Cells were either treated with doxycycline (dox) for 18 h or left untreated. c Schematic representation of
the screen workﬂow. d Distribution of ICOS mean ﬂuorescence intensity (MFI) in HeLa reporter cells after transfection with Roquin-1-targeting siRNA
pools (siRc3h1) or non-targeting control siRNAs (siCtrl) in a 96-well plate. The Z′ factor was calculated from mean and SDs of positive (siRc3h1) and
negative (siCtrl) control data. e Normalized screen data of the customized siRNA library for Roquin-1 cofactors. ICOS MFI of each sample was normalized
into a Z score based on plate mean and SD. Ranked Z scores are shown for each siRNA pool. Each data point with an average Z score >2 was considered a
hit
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with Fmrp, and that localization of Roquin into RNA granule-like
structures is likely independent of Fmrp or Nuﬁp2.
We next investigated the cellular localization of NUFIP2 to
RNA granule-like structures by super-resolution microscopy in
MEF cell lines and ﬂow cytometry imaging in primary CD4+
T cells (Fig. 4b, Supplementary Figs. 3, 4, 5a−e). Although
NUFIP2 was named nuclear FMRP interacting protein 2 due to
its nucleo-cytoplasmic relocalization during different phases of
the cell cycle36, we found retrovirally expressed GFP-NUFIP2 to
be predominantly localized in the cytoplasm of T cells (Fig. 4b).
Cytoplasmic localization of NUFIP2 was observed throughout all
phases of the cell cycle (Fig. 4b and Supplementary Fig. 3a–c), and
was unchanged in the absence of Roquin (Supplementary
Fig. 3d–f). As described previously37, both endogenous and
overexpressed NUFIP2 aggregated into stress granules in
response to arsenite-induced oxidative stress (Supplementary
Figs. 4a, b, 5a−c). However, we observed a partial enrichment of
NUFIP2 in P bodies (Supplementary Figs. 4a, 5a, c), where it
colocalized with Roquin-1 (Supplementary Fig. 4a).
Neither absence of NUFIP2 affected Roquin-1 localization to P
bodies or stress granules (Supplementary Fig. 5d, e), nor did
the absence of Roquin interfere with aggregation of NUFIP2 in
stress granules (Supplementary Fig. 4b). However, the speciﬁc
enrichment of NUFIP2 in P bodies (Supplementary Figs. 4a, 5c)
was not observed anymore in the absence of Roquin expression
(Supplementary Fig. 4b).
We investigated the expression proﬁle of Nuﬁp2 in mouse
tissues and upon T-cell stimulation. Nuﬁp2 was expressed highest
in the brain, but also enriched in spleen, lymph node, thymus,
and lung compared to lower expression levels in heart, muscle,
kidney, and liver (Fig. 4c). Notably, highest expression of Nuﬁp2
protein correlated with high Roquin levels11, and T-cell
stimulation signiﬁcantly increased protein expression of Nuﬁp2
and Roquin-1 and Roquin-2 (Fig. 4d). This effect was not
increased further by addition of agonistic antibodies against the
costimulatory receptors CD28 or ICOS (Fig. 4d). In contrast,
stimulation with the cytokines IL-2, IL-6 and IL-10, the latter of
which has been shown to induce Roquin-1 mRNA expression38,
was not able to elevate either Nuﬁp2 or Roquin-1 and Roquin-2
protein levels under conditions that effectively induced phos-
phorylation of Stat3 or Stat5 (Supplementary Fig. 5f). Analyzing
Nuﬁp2 protein amounts in peripheral CD4+ T cells, we found
that deletion of the Roquin encoding alleles also caused a
reduction in the Nuﬁp2 protein (Fig. 4e), which could not be
accounted for by a comparably small decrease of Nuﬁp2 mRNA
levels (Supplementary Fig. 5g). Accordingly, Nuﬁp2 expression
was restored in Roquin-deﬁcient MEF cells upon retroviral
reconstitution with Roquin-1 (Fig. 4f), while mRNA levels stayed
constant (Fig. 4g). Interestingly, rescue of Nuﬁp2 expression
occurred when cells were reconstituted with wild-type Roquin,
but also upon expression of RNA-binding (RoquinK220A K239A
R260A) or post-transcriptional inactive (aa 1–509) Roquin-1
mutants, or upon expression of the sanroque mutant of
Roquin-1, Roquin-1M199R (Fig. 4f). These results suggest that
Roquin stabilizes Nuﬁp2 on the post-translational level.
Direct physical interaction between Roquin and NUFIP2. Since
NUFIP2 was destabilized in the absence of Roquin, we tested
whether both proteins interact. Overexpressed NUFIP2 co-
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immunoprecipitated with GFP-Roquin-1 from HEK293T cell
lysates using anti-GFP antibodies in an RNase-insensitive manner
(Fig. 5a). Surprisingly, Roquin-1 interacted with NUFIP2 through
the amino-terminus (aa 1–509), harboring the RING ﬁnger and
ROQ domain, and not through the carboxy-terminal sequences
(aa 509–1130) that have been proposed to mediate protein
−protein interactions (Fig. 5b and Supplementary Fig. 6a).
Underscoring the physiologic importance of this interaction,
endogenous Nuﬁp2 was strongly enriched in immunoprecipitates
of endogenous Roquin from MEF cell lysates using anti-Roquin-
1/2–speciﬁc antibodies (Fig. 5c). This interaction still occurred
with the sanroque mutant of Roquin-1 (Fig. 5c). Notably,
immunoprecipitating Nuﬁp2 from lysates of individual Roquin-1
or Roquin-2 knockout cells revealed indistinguishable co-
immunoprecipitation with either paralog (Fig. 5d). The NUFIP2
(aa 255–411) internal fragment was essential for the interaction,
since neither amino-terminal (aa 1–255) nor carboxy-terminal
sequences (aa 411–695) co-immunoprecipitated with Roquin-1
(Fig. 5e, Supplementary Fig. 6a). Finally, we puriﬁed recombinant
proteins produced in bacteria (Fig. 5f) and demonstrated a direct
interaction between mouse Roquin-1 (aa 2–441) and human
NUFIP2 (aa 255–411) by surface plasmon resonance (SPR)
experiments (Fig. 5g). The calculated equilibrium dissociation
constant (KD) of 182 nM indicates a strong physical interaction
(Fig. 5h).
Since the same fragment of NUFIP2 that mediated interaction
with Roquin has also been shown to engage in a direct interaction
with an amino-terminal fragment of Fmrp (aa 1–132), we
wondered whether the interaction between NUFIP2 and Roquin
and between NUFIP2 and Fmrp were mutually exclusive or
NUFIP2
TUBULIN
siC
trl
siN
UF
IP2
N
UF
IP
2 
m
R
N
A 
re
l.
to
YW
H
AZ
75
100
63
48
G
FP
SSC
105
104
103
102
101
100
100
K
GFP-Nufip2
GFP-Nufip2hi
GFP-Nufip2med
GFP-Nufip2lo
GFP-Nufip2
siNUFIP2#2
GFP
15
0K
200
K
25
0K50
K0
GFPhi
GFPmed
GFPlo
GFPhi
GFPmed
GFPlo
GFP-Nufip2hi
GFP-Nufip2med
GFP-Nufip2lo
GFPhi
GFPmed
GFPlo
GFPhi
GFPmed
GFPlo
GFPhi
GFPmed
GFPlo
GFPhi
GFPmed
GFPlo
d
TUBULIN
NUFIP2
GFP-NUFIP2
kDa
75
48
100
siC
trl
siC
NO
T1
siN
UF
IP2
R
el
. n
or
m
.
IC
O
S 
M
FI
1
2
3
4
5
6
7
*
0
CNOT1
TUBULIN
kDa
245
63
48
0
0.2
0.4
0.6
0.8
1.0
0
0.2
0.4
0.6
0.8
1.0
siC
trl
siC
NO
T1
kDa
GFP
Rel. norm. ICOS expr..
Rel. norm. ICOS expr.
siNUFIP2#4
*
n.d.
0 4 6 8
0 2
2
4 6
siNUFIP2
siCtrl
siCNOT1
siCtrl+
+
–
–
+
+
–
–
GFP
GFP-NUFIP2+
+
–
–
CN
O
T1
 
m
R
N
A 
re
l.
to
YW
H
AZ
NS
NS
8
IC
O
S 
m
R
N
A 
re
l. 
to
 Y
W
H
AZ
 (%
)
Time after actinomycin D (min)
0 30 60 90 120 150 180 210 240
0
20
40
60
80
100
120
t1/2= 360.1 min
t1/2= 344.6 min
t1/2= 231.8 min
t1/2= 157.7 min
siCtrl
siNUFIP2
siRC3H1; siRC3H2
siNUFIP2; siRC3H1; siRC3H2
g
0.0
0.2
0.4
0.6
0.8
1.0
0.0
0.2
0.4
0.6
0.8
1.0
0.0
0.2
0.4
0.6
0.8
1.0
N
UF
IP
2 
m
R
N
A 
re
l.
to
YW
H
AZ
siC
trl
siN
UF
IP2
R
C3
H1
 
m
R
N
A 
re
l.
to
YW
H
AZ
R
C3
H2
 
m
R
N
A 
re
l.
to
YW
H
AZ
siN
UF
IP2
;
siR
C3
H1
; s
iR
C3
H2 siC
trl
siR
C3
H1
; s
iR
C3
H2
siN
UF
IP2
;
siR
C3
H1
; s
iR
C3
H2 siC
trl
siR
C3
H1
; s
iR
C3
H2
siN
UF
IP2
;
siR
C3
H1
; s
iR
C3
H2
e f h
a b c
Fig. 3 ICOS repression by NUFIP2 depends on Roquin expression. a MFI of ICOS expression or b qPCR analysis of NUFIP2 and CNOT1 relative to YWHAZ
mRNA expression after siRNA knockdown of NUFIP2 or CNOT1 in HeLa reporter cells using siGENOME siRNA pools. c Immunoblot analysis of NUFIP2 and
CNOT1 expression in HeLa reporter cells after treatment with the siGENOME NUFIP2 or CNOT1 siRNA pool, respectively. d Immunoblot analysis of NUFIP2
expression in reporter cells that were transduced with GFP- or GFP-NUFIP2 by retroviral infection. e Flow cytometry analysis of GFP expression in HeLa
reporter cells that were transduced with different amounts of GFP- or siRNA-resistant GFP-NUFIP2 by retroviral infection. f GFP- or siRNA-resistant GFP-
NUFIP2-expressing reporter cells from e were transfected with NUFIP2-targeting or control siRNAs and Roquin expression was induced with doxycycline.
ICOS expression was measured by ﬂow cytometry and normalized to siCtrl-treated cells. ICOS expression in cells with high (hi) or intermediate (med)
GFP-expression is compared with that of low (lo) GFP-expressing cells. g qPCR analysis of NUFIP2, RC3H1, and RC3H2 mRNA expression in HeLa reporter
cells after transfection with the indicated siRNAs. Expression relative to the reference gene YWHAZ was normalized to the non-targeting control. h ICOS
mRNA decay curves of HeLa reporter cells after treatment with the siGENOME NUFIP2-targeting siRNA pool, a combination of siRNAs against RC3H1 and
RC3H2 (Invitrogen) or a combination of all three targets or a non-targeting control siRNA. Forty-eight hours after transfection, cells were seeded for
treatment with 5 µg/mL actinomycin D the next day. Cells were treated for 30–240min and ICOS expression was determined by qPCR analysis and
normalized to YWHAZ. In c and e representatives of three independent experiments are shown. Error bars in a, b, d, f, g, and h represent mean and SDs of
three (a, b, f, g) or four (d, g, h) independent experiments. mRNA half-life in h was calculated with Graph Pad Prism from four independent experiments. In
a and f statistical signiﬁcance was calculated with one-way ANOVA Kruskal−Wallis test followed by Dunn’s multiple comparisons test (*p< 0.05)
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02582-1 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:299 |DOI: 10.1038/s41467-017-02582-1 |www.nature.com/naturecommunications 5
enabled formation of a ternary complex. To answer this question,
we puriﬁed the fragment of Fmrp (aa1–132) (Fig. 6a) that binds
to NUFIP2 (Fig. 6b), and assayed binding of Roquin to NUFIP2
by SPR in the presence of Fmrp protein. Addition of Fmrp
inhibited the binding of NUFIP2 (aa 255–411) to immobilized
Roquin-1 (aa 2–441) in a concentration-dependent way (Fig. 6b).
Consistently, less Roquin was co-immunoprecipitated with
Nuﬁp2 from cell lysates when Fmrp was overexpressed in the
cells (Fig. 6c). These results demonstrate a mutually exclusive
interaction of NUFIP2 with Fmrp or Roquin-1, which likely leads
to competition for binding to NUFIP2 by Roquin and Fmrp.
However, analyzing prototypical Roquin functions in mice
lacking both alleles of the Fmrp-encoding gene Fmr1 (Fmr1−/−
mice), there was no indication for a gain of Roquin function,
since those animals contained comparable frequencies of effector-
like (CD62− CD44+) or regulatory T cells in secondary lymphoid
organs (Fig. 6d, e). Furthermore, ICOS surface expression was not
changed in T cells with Fmr1−/− compared to wild-type genotypes
when we analyzed Foxp3+ regulatory CD4+ T cells (Fig. 6e, f) or
conventional CD4+ T cells without (Fig. 6g, 0 day) or with
stimulation in a 6-day culture (Fig. 6g).
Roquin and NUFIP2 cooperatively bind to cis-elements. As
previously reported, progressive 3′ shortening of the full-length
human ICOS 3′-UTR (1–2478) leads to a gradual reduction in the
repression of ICOS by overexpressed Roquin-1 (Supplementary
Fig. 6b)15. This implies the existence of multiple alternative
binding sites for overexpressed Roquin-1 in the ICOS 3′-UTR. To
determine which cis-elements in human ICOS respond to endo-
genous Roquin, we evaluated ICOS 3′-UTR deletion constructs in
a Rc3h1ﬂ/ﬂ; Rc3h2ﬂ/ﬂ; Cre-ERT2 MEF cell line before and after 4′
OH-tamoxifen-inducible deletion of Roquin-encoding alleles
(Fig. 7a and Supplementary Fig. 6c). Strikingly, derepression
occurred when the 3′-UTR of the ICOS mRNA was shortened
from the 3′ end to 2211 nts or beyond, while constructs with at
least 2271 nts were fully repressed by endogenous Roquin. These
results suggest that a critical Roquin-regulated cis-element is
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present between nucleotides 2211 and 2271 of ICOS mRNA, a
region that has already been implicated in Roquin-mediated
regulation of ICOS via a miR-101 binding site17,33. However, our
data demonstrated direct binding of Roquin to the ICOS 3′-UTR,
and reporter analyses in Dicer- or Argonaute-deﬁcient cells
revealed Roquin-1-dependent repression of ICOS in an miRISC-
independent manner15.
Roquin has been shown to bind conserved tri-loop2–4,6 or
hexa-loop structures1 in vitro. Additionally, crosslinking and
immunoprecipitation experiments showed interaction with pre-
dicted U-rich stem-loops of different lengths in cells7. Therefore,
we employed the LocARNA algorithm39 for the identiﬁcation of
evolutionary conserved structured motifs within the mapped
region of the ICOS 3′-UTR. Two conserved stem-loops, an octa-
loop with a U-rich loop and a tri-loop without characteristics of
the canonical CDE6, were identiﬁed in the mapped region
between nts 2211–2271 (Fig. 7b). To determine how Roquin
recognizes the mapped cis-element we performed electrophoretic
mobility-shift assays (EMSAs) with recombinant Roquin-1 (aa
2–441) and in vitro-transcribed RNA. We extended the mapped
sequence at the 5′ end by 28 nts to facilitate correct folding of the
predicted octa-loop structure (ICOS nts 2183–2271). Roquin
bound strongly to the mapped cis-element (nts 2183–2271)
(Fig. 7c). The mode of interaction with this cis-element was
further addressed by competition experiments. Efﬁcient competi-
tion was only obtained through the unlabeled full cis-element (nts
2183–2271) RNA, whereas shorter RNA fragments were unable
to affect the binding (Supplementary Fig. 6d). In line with this,
Roquin bound only very weakly to shorter RNA fragments
representing the full octa-loop containing element (Fig. 7d), the
element containing only the 5′ part of the octa-loop (Fig. 7e) or
the extended tri-loop containing element (Fig. 7f). Surprisingly, in
contrast to its interaction with the CDE3,6, Roquin did not bind to
the isolated tri-loop-containing element (Fig. 7g). Nevertheless,
additional experiments established that also this unconventional
tri-loop can contribute to regulation. In reporter assays carried
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out in Roquin-deﬁcient MEF cells with doxycycline-inducible
overexpression of Roquin-1, the ICOS 3′-UTR deletion construct
that ended before the tandem cis-element (F2 in Supplementary
Fig. 6e) only showed half of the reporter regulation as compared
to full-length ICOS mRNA (wt) (Supplementary Fig. 6e).
Additional deletion of a region encompassing the much further
5′ localized Roquin-bound CDE-like stem-loop (F3), which we
have identiﬁed earlier by mapping the Roquin/ICOS mRNA
interaction11,40, attenuated the reporter regulation even more. On
the other hand, neither the deletion of this CDE-like element
alone affected reporter regulation (F1) nor did the combined
deletion of the CDE-like tri-loop element together with the
perfect consensus CDE at the very end of the 3′-UTR (F4). These
data indicated a cooperative function of the CDE-like tri-loop
element and the unconventional tandem cis-element located
hundreds of nucleotides downstream. To conﬁrm that all three
stem-loops in both cis-elements contribute to Roquin-mediated
ICOS repression in a cooperative manner, we tested ICOS
reporters with single and combined double and triple point
mutations in the loop-forming sequences (Fig. 7h, i). Mutating
the loop of the CDE-like tri-loop (M1) or the octa-loop of the
tandem element (M2) were much less effective compared to the
mutation of the tri-loop in the tandem element (M3), which
almost completely inhibited the regulation of the ICOS reporter
by endogenous Roquin proteins (Fig. 7i). However, combining
the mutations of CDE-like and octa-loop (M1 M2) impaired
Roquin-mediated regulation to a similar extent, indicating the
cooperative activity of all three stem-loops. This assumption
received further support by the observed complete inhibition of
regulation in all other combinations of two or more mutations
(Fig. 7i compare M1 M2, M2 M3, M1 M3 or M1 M2 M3).
Interestingly, the shortening or deletion of sequences between the
CDE-like tri-loop and the tandem cis-element increased the
regulation of the reporter by endogenous Roquin proteins
(Fig. 7h, j).
Since NUFIP2 has been shown to interact with polyadenylated
RNA36, we tested whether NUFIP2 would bind directly to the
mapped ICOS cis-element or to another tandem element present
in the Ox40 3′-UTR that is required for the regulation of the Ox40
costimulatory receptor1,3,40. Speciﬁcally, we performed EMSAs
with NUFIP2 (aa 255–411) and Roquin (aa 2–441) either with the
ICOS RNA (nts 2183–2271) (Fig. 8a–c) or Ox40 (nts 1064–1126)
(Fig. 8d–f). Compared to Roquin (Fig. 8b), NUFIP2 bound the
ICOS cis-element with much lower afﬁnity (Fig. 8a), which was
similarly true for the Ox40 cis-element (Fig. 8d, e). We next
investigated whether NUFIP2 interacted with the cis-element in
the presence of Roquin. Intriguingly, addition of NUFIP2 caused
a super-shift of Roquin-1-bound ICOS (nts 2183–2271) (Supple-
mentary Fig. 7a), indicating the formation of a ternary complex.
Quantifying the interaction of Roquin with these cis-elements in
binary or NUFIP2-containing ternary complexes showed a 3–4-
fold better binding in the presence of NUFIP2 (Fig. 8b, c, e, f and
Supplementary Fig. 7b, c). These results support a model in which
NUFIP2 increases the binding afﬁnity of Roquin in a ternary
complex with the mapped ICOS or Ox40 cis-elements. Further-
more, the data explain how these unconventional cis-elements are
recognized at low or endogenous levels of Roquin (Supplemen-
tary Fig. 7d).
Discussion
The family of RNA-binding proteins has been extended enor-
mously by recent ﬁndings showing that proteins without known
RNA-binding domains interact with mRNA inside cells28,41. The
current challenge therefore is to elucidate how such interactions
contribute to speciﬁc post-transcriptional gene regulation.
Employing a targeted siRNA screening approach, we identiﬁed
and characterized NUFIP2 as a cofactor of Roquin function. So
far, little is known about the composition of the mRNP assem-
bling around Roquin. It has been previously shown that the
carboxy-terminus of Roquin-1 interacts with the deadenylase
complex5,6. Furthermore, the amino-terminal part of Roquin-1
interacts with Ddx6/Rck and Edc4, two cofactors of mRNA
decapping15. However, it is unclear whether these interactions are
direct. In contrast, NUFIP2 not only co-immunoprecipitated with
full-length and amino-terminal fragments of Roquin-1 from cell
lysates, but also interacted as puriﬁed recombinant Roquin-1 and
NUFIP2 protein fragments with high afﬁnity (KD of <200 nM).
NUFIP2 is therefore a direct binding partner of the amino-
terminal part of Roquin. The recently reported direct interaction
of NUFIP2 and Ddx637 may further enhance Roquin-dependent
post-transcriptional repression. However, since recruitment of the
carboxy-terminus of Roquin was sufﬁcient to induce reporter
mRNA degradation, this interaction may not be required5.
A molecular property that connects Roquin and NUFIP2 is
their shared localization in RNA granules. For some instances of
such co-localization the biophysical basis has been demonstrated
to lie in the aggregation of RNA-binding proteins containing
LCR. They are enriched in polar amino acids like asparagine,
glutamine, serine, tyrosine and glycine42. In fact such LCRs with
enrichment in glutamine and asparagine can be found in peptide
sequences of NUFIP2 as well as of Roquin15,37. We used a
recently developed biochemical assay to precipitate proteins that
have a tendency to aggregate with b-isoxazole35 and also deter-
mined the localization of Roquin or NUFIP2 in Nuﬁp2- or
Roquin-deﬁcient cells. In these experiments we show that both
proteins aggregate, albeit with different b-isoxazole concentration
requirements, and localize to stress granules independent of each
other. Nevertheless, upon overexpression of Roquin, NUFIP2
becomes enriched in P bodies. Together these data reveal that the
binary interaction between NUFIP2 and Roquin is not a driving
force for heterotypic aggregation of both proteins, but may rather
be involved in speciﬁc functions of both proteins.
Our work demonstrates the importance of NUFIP2 in Roquin-
mediated ICOS-regulation. This target mRNA shows interesting
and unconventional features: ﬁrst, with 1978 nts the 3′-UTR of
ICOS is remarkably long. The 3′-UTR contains multiple non-
essential binding sites, at least one of which forms a perfect CDE.
Furthermore, the mapped essential cis-element is composed of
tandem stem-loops that are both required for efﬁcient recognition
by Roquin. Finally, this essential tandem stem-loop appears to
depend functionally on additional binding of Roquin to another
binding site being located in a long distance. We have observed
before a cooperation of two binding sites in the Ox40 3′-UTR to
equally and independently contribute to Roquin-induced mRNA
decay1. It was therefore surprising to ﬁnd that in the ICOS 3′-
UTR the remotely 5′ located binding site enables the function of
the essential 3′ binding site, while the sequences between both cis-
elements appeared to inhibit post-transcriptional repression by
Roquin. These ﬁndings suggest an additional level of regulation
involving the secondary structure of this 3′-UTR, which may
dynamically change the physical distance of both elements and
therefore enable or reduce the effect of the bound trans-acting
factors.
Roquin bound to the essential cis-element of the ICOS 3′-UTR
with enhanced afﬁnity in the presence of NUFIP2, and similar
results were obtained for another Roquin-regulated tandem stem-
loop containing cis-element from the Ox40 3′-UTR. A question
that remains to be answered is how exactly NUFIP2 increases the
binding afﬁnity of Roquin to the mapped regions. One possibility
is that NUFIP2 binding may promote Roquin to adopt a certain
conformation thereby enabling additional or stronger contacts of
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its RNA binding domain to speciﬁc RNA elements (Supple-
mentary Fig. 7d). Such a mechanism of cofactor-dependent
changes in binding afﬁnity has recently been shown for the yeast
DEAD box protein Rok1, which interacts with a dsRNA duplex in
the pre-rRNA between 5.8 S and 18 S rRNAs. Target speciﬁcity of
Rok1 was established by binding to its cofactor Rrp5. Rrp5
binding induced changes in the Rok1 secondary structure,
thereby enhancing Rok1 target speciﬁcity without binding to
RNA itself 43.
On the other hand, NUFIP2 was originally described as an
RNA-binding protein recognizing poly(G) homopolymers36. It
might therefore bind RNA sequence or structure elements in the
ICOS 3′-UTR by itself. Considering the mapped cis-element and
the higher afﬁnity of Roquin for this element, it is more likely that
Roquin recruits NUFIP2 to this speciﬁc RNA element than vice
versa. In this scenario NUFIP2 contributes, in a complex with
Roquin, additional contacts to the recognized cis-element and
thereby enhances or alters sequence and shape-speciﬁc RNA
recognition by Roquin (Fig. 8c, f). Very recently a similar scenario
has been described for ASH1 mRNA recognition by a motor-
transport complex in budding yeast44. In the nucleus She2p
recognizes cis-elements in the RNA with modest afﬁnity and
speciﬁcity. After nuclear export, the RNA-binding protein and
myosin adapter She3p joins the complex, thereby improving
afﬁnity and speciﬁcity for ASH1 mRNA. A crystal structure of the
ternary yeast complex revealed that She3p improves binding by
joining the complex as an unfolded protein, contacting both the
globular She2p protein and the RNA44. In analogy, also the RNA-
binding ROQ domain of Roquin is globular, whereas the inter-
acting NUFIP2 fragment is largely unfolded45 and modulates the
RNA binding. Given the large number of recently discovered
unfolded RNA-binding proteins28,41,46, it is likely that more
examples are to be discovered, where unfolded proteins such as
NUFIP2 modulate the RNA binding and function of globular
proteins like Roquin. Our study provides evidence that also the
combination of different RNA cis-elements contribute to the
complexity and precision of post-transcriptional regulation.
Future experiments should address whether the physical and
functional cooperation of Roquin and NUFIP2 is speciﬁc for
certain cis-elements and target mRNAs and whether NUFIP2 also
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Fig. 8 Cooperative binding of NUFIP2 and Roquin to response elements in ICOS and Ox40 mRNA. a EMSA performed with the ICOS (nt 2183–2271) RNA
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increases the afﬁnity and adapts the speciﬁcity to distinct cis-
elements in target mRNAs of FMRP. Regardless of these open
questions, our ﬁndings contribute to the emerging view that post-
transcriptional control appears to rely on a complex code of cis-
and trans-acting elements, reminiscent of what has been shown
for transcriptional control.
Methods
Cloning. ICOS reporter constructs consisting of human ICOS coding sequence
followed by fragments of the ICOS 3′-UTR or the TNF CDE260 have been described
previously8,15. Expression constructs for Roquin-1, Roquin-1san, GFP-Roquin-1
full-length, GFP-Roquin-1 (aa 1–509), GFP-Roquin-1 (aa 509–1130), GFP, and
Regnase-1 have been described previously8,15. For generation of Roquin-1-P2A-
mCherry, a mammalian codon-optimized sequence encoding an SGSG-linker
followed by P2A-mCherry was synthesized by Entechelon GmbH (now Euroﬁns
Genomics) and cloned behind the coding sequence of Roquin-1 via NotI restriction
sites. Human NUFIP2 was ampliﬁed from cDNA clone IMAGE:40128910 obtained
from Source BioScience LifeSciences. NUFIP2, NUFIP2 (aa 255–411), NUFIP2 (aa
411–695), and mouse Fmrp (aa 1–132) were ampliﬁed from cDNA using forward
and reverse primers. Primer sequences are listed in Supplementary Table 1. To
generate GFP-NUFIP2, NUFIP2 cDNA was cloned downstream of GFP as
described previously47. siRNA-resistant GFP-NUFIP2, stem-loop mutants (M1
−M3), or deletion constructs (delA, delB, delC) of the ICOS 3′-UTR reporter were
obtained by introducing targeted mutations into plasmid DNA using the Quik-
Change® II XL Site-Directed Mutagenesis Kit (Agilent) according to the manu-
facturer’s instructions. Site-directed mutagenesis was also employed for generation
of the N-terminal NUFIP2 protein fragments (NUFIP2 aa 1–255 and aa 1–411) by
introducing STOP codons at deﬁned positions within the cDNA. Primer sequences
are listed in Supplementary Tables 1 and 3. cDNAs were cloned into retroviral
expression vectors (KMV IRES GFP, MSCV IRES Thy1.1 or pRetroX-Tight) or
transient transfection vectors (pDest12, pLNCX2) as described before1,3,11,15. For
doxycycline-inducible lentiviral gene expression, sequences encoding Roquin-1 or
Roquin-1-P2A-mCherry were inserted into plentiCMVtight Neo DEST (Addgene
plasmid #26432). plentiCMVtight Neo DEST, the rtTA3-encoding vector plenti
CMV rtTA3 Blast (Addgene plasmid #26432) and plenti PGK Hygro DEST for
stable lentiviral gene expression (Addgene plasmids #19066) were donated by Dr.
Eric Campeau48.
Expression and puriﬁcation of recombinant proteins. Expression of Roquin-1
(aa 2–441) has been described previously1,3. For expression of NUFIP2 (aa
255–411), the fragment was inserted into the pOPINS3C and expressed as N-
terminal His6-SUMO-fusion protein together with a C-terminal His6 tag in
Escherichia coli BL21(DE3)pRIL. Cells were grown at 37 °C in LB medium with
100 μg/mL ampicillin and 34 μg/mL chloramphenicol. At OD600 = 0.7, the cell
cultures were induced by adding 0.5 mM isopropyl β-D-1-thiogalactopyrano-
side (IPTG) and overnight growing conditions changed to 20 °C. Next, the cells
were harvested and resuspended in lysis buffer (500 mM NaCl, 20 mM imidazole,
0.1% Tween20, 10 μg/mL DNase I, protease inhibitors, 50 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), pH 7.5) and sonicated at 4 °C. After
centrifugation, the cleared lysates were applied to a HisTrap FF column (GE
Healthcare). The His6-SUMO tag was cleaved off by PreScission protease digestion
at 4 °C overnight and removed using the ion exchange columns HiTrap Q FF and
HiTrap SP FF (GE Healthcare). Protein bound to the HiTrap SP FF column was
concentrated and further puriﬁed using a Superdex 75 10/300 GL column
(Amersham Pharmacia Biosciences) in 200 mM NaCl and 50 mM HEPES pH 7.5
buffer.
Fmrp (aa 1–132) was inserted into the pOPINJ and expressed as N-terminal
His6-GST-fusion protein in E. coli BL21Star(DE3). Cells were grown at 37 °C in LB
medium with 100 μg/mL ampicillin until they reached OD600 = 0.7. Then 0.5 mM
IPTG was induced to the cell cultures and left to grow overnight at 20 °C. In the
morning the cells were harvested, resuspended in lysis buffer (500 mM NaCl, 20
mM imidazole, 0.1 % Tween20, 10 μg/mL DNase I, protease inhibitors, 50 mM
HEPES, pH 7.5) and sonicated at 4 °C. The lysates were centrifuged and the
supernatant was applied to a HisTrap FF column (GE Healthcare). His6-GST tag
was cut off by the PreScission Protease at 4 °C overnight and then removed using a
GSTTrap FF column (GE Healthcare) and GST beads (Glutathione Sepharose High
Performance; GE Healthcare). The unbound protein was concentrated and gel
ﬁltrated using a HiLoad 16/600 Superdex 75 pg (Amersham Pharmacia
Biosciences) in 250 mM NaCl and 10 mM HEPES pH 7.5. The different puriﬁed
proteins were ≥95% pure with OD 260/280 values below 0.65 indicating that the
proteins were essentially free of nucleic-acid contaminations.
Surface plasmon resonance. A BIACORE 3000 instrument (Biacore Inc.) was
used to analyze Roquin-NUFIP2 binding. Roquin (aa 2–441) was immobilized on
the CM5 sensor chip with amine coupling (Biacore Inc.) at a concentration of 50
μg/mL in 10 mM sodium-phosphate buffer pH 5.7. NUFIP2 (aa 255–411) was
injected onto the sensor chip using the concentrations 0.063, 0.125, 0.25, 0.5, 1, 2,
and 4 μM at 30 μL/min ﬂowrate and at 20 °C in running buffer (150 mM NaCl,
0.05% Tween20, 10 mM HEPES). When NUFIP2 (aa 255–411) and FMRP (aa
1–132) were injected together, the concentration of NUFIP2 was 4 μM and the
concentrations of FMRP were 0.016, 0.063, 0.25, and 1 μM in the running buffer
(250 mM NaCl, 0.05% Tween20, 10 mM HEPES). The equilibrium dissociation
constant KD was calculated from steady-state measurements using the BIAeva-
luation program (Biacore Inc.).
RNAs. The ICOS (nt 2232–2250) RNA fragment was purchased from IBA GmbH
(Göttingen, Germany), where it was synthesized and puriﬁed via PAGE (poly-
acrylamide gel electrophoresis) followed by two steps of desalting.
The ICOS (nt 2183–2271), (nt 2193–2216), (nt 2224–2253), (nt 2251–2271), (nt
2183–2226), and Ox40 (nt 1064–1126) RNA fragments were in vitro-transcribed
using the MEGAshortscriptTM Kit (Ambion). Primers with the T7 promoter
sequence at the 5′ end that were used as templates for in vitro transcription are
listed in Supplementary Table 3. After transcription, the RNA was puriﬁed based
on manufacturer’s instructions, starting with DNase digestion, proceeding with
phenolic extraction, followed by RNA precipitation using ethanol. The integrity of
the RNA was conﬁrmed by native or denaturing urea PAGE.
The library of siGENOME siRNA pools was custom-made. Individual siRNA
duplexes targeting STAU1 (D-011894-01, D-011894-02, D-011894-03, D-011894-
04), CNOT1 (D-015369-01, D-015369-02, D-015369-03, D-015369-04) and
NUFIP2 (D-021280-01, D-021280-03, D-021280-04, D-021280-17) as well as
Roquin-targeting siRNA pools (M-044230-01) and non-targeting control siRNAs
(D-001210-01) were from GE Healthcare (Dharmacon, Lafayette, CO, USA), in
addition, published siRNA sequences9 against RC3H1 (5′-
GAUCGAGAGUUACUAUCCAdTdT-3′) or RC3H2 (5′-
GCUUGAAAAGUAUCGAUUAdTdT-3′) were custom synthesized (Invitrogen).
Electrophoretic mobility-shift assay. RNA fragments for electromobility shift
assays (EMSAs) were radioactively labeled using T4 polynucleotide kinase and
[γ32P]ATP. Sepharose spin columns (NucAway; Ambion) were used to separate
the RNA from free nucleotides. The radioactively labeled RNA (5 nM), the Roquin-
1 protein (aa 2–441) and the tRNA competitor (30 μg/mL) were incubated in
Hepes/NaCl/MgCl2 (HNM) buffer (10 mM HEPES pH 7.5, 150 mM NaCl, 2 mM
MgCl2) and 4% glycerol in the ﬁnal volume of 20 μL for 30 min at 25 °C. In
competition experiments, unlabeled competitor RNA was added afterwards and
incubated for another 15 min at 25 °C. The samples were resolved by native Tris/
Borate/EDTA (TBE) PAGE (4% polyacrylamide, 1× TBE buffer). Gels were ana-
lyzed using radiograph ﬁlms or Fuji Imaging plates exposed in the FLA-3000, after
15 min incubation in ﬁxing solution (30% (vol/vol) methanol, 10% (vol/vol) acetic
acid) and vacuum drying. The signal was quantiﬁed using ImageJ (version 1.51).
The curve ﬁtting and the calculation of the KDs was done using the software Origin
(version 9.0.0G).
Mice and cell culture. The mouse lines Rc3h1ﬂ/ﬂ; Rc3h2ﬂ/ﬂ; CAG-CARSTOP-ﬂ;
CreERT2 (denoted Rc3h1ﬂ/ﬂ; Rc3h2ﬂ/ﬂ; Cre-ERT2), Rc3h1ﬂ/ﬂ; Rc3h2ﬂ/ﬂ; Cd4-Cre-
ERT2; rtTA and Rc3h1ﬂ/ﬂ; Rc3h2ﬂ/ﬂ; Cd4-Cre (denoted Rc3h1/2ﬂ/ﬂ; Cd4-Cre) and
Fmr1−/− mice have been described previously1,3,11,49. All animals were housed in a
pathogen-free barrier facility in accordance with the Helmholtz Zentrum
München, the Ludwig-Maximilians-University München, and Erasmus MC insti-
tutional, state, and federal guidelines. HEK293T cells, Rc3h1/2−/− mouse embryonic
ﬁbroblast (MEF) cells, and Zc3h12a−/−MEF cells have been described before8,15.
MEF, HEK293T, and HeLa cells were cultured in a cell culture incubator at 37 °C,
10% CO2 in DMEM (ThermoFisher Scientiﬁc) supplemented with 10% (v/v) fetal
bovine serum (FBS) (PAN BIOTECH), penicillin-streptomycin (100 U/mL)
(ThermoFisher Scientiﬁc) and 10 mM HEPES, pH 7.4 (ThermoFisher Scientiﬁc).
Primary mouse T cells were cultured at 37 °C, 10% CO2 in DMEM supplemented
with 10% (v/v) FBS, 10 mM HEPES pH7.4, penicillin-streptomycin (100 U/mL),
non-essential amino acids (ThermoFisher Scientiﬁc), and 50 μM β-
mercaptoethanol (Sigma-Aldrich).
Mouse CD4+ T cells were isolated from spleen and lymph nodes of C57BL/6
mice with the EasySepTM Mouse CD4+ T-cell Isolation Kit (StemCell
Technologies). For activation, T cells were stimulated with anti-CD3 (0.25 μg/mL)
and anti-CD28 (2.5 μg/mL) on six-well plates coated with goat-anti-hamster
immunoglobulin G (IgG) (0.05 mg/mL in phosphate buffered saline (PBS)) for 40 h
and skewed towards Th1 differentiation by addition of IL-12 (10 ng/mL) and anti-
IL-4 (10 μg/mL). After stimulation, cells were expanded in complete media
containing 20 U/mL of recombinant human IL-2 (ProleukinS, Novartis) for
2–4 days.
For cytokine stimulation, cells were kept in complete media without IL-2 24 h
prior stimulation with anti-CD3 (0.25 μg/mL) in combination with anti-CD28 (2.5
μg/mL) or anti-ICOS (2.5 μg/mL) for 12 h. Alternatively, cells were incubated in
media containing IL-2 (20 U/mL), IL-6 (5 ng/mL), IL-10 (50 ng/mL) or anti-CD3
and anti-CD28 for 20 h.
Antibodies and reagents. Monoclonal antibodies against Roquin-1 and Roquin-2
(3F12, 18F8, Q-4-2), CD3 (145-2C11), and CD28 (37N) have been described
before8,11,15. To generate monoclonal antibodies against NUFIP2, a Wistar RjHan:
WI rat was immunized with puriﬁed GST-tagged full-length human NUFIP2
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protein using standard procedures as described50. The hybridoma cells of NUFIP2-
reactive supernatants were cloned twice by limiting dilution. Experiments in this
study were performed with NUFIP2 23G8 (rat IgG2b/κ) and 14G9 (rat IgG2a/κ).
Antibodies against Tubulin (B-5-1-2), G3bp1 (sc-81940), and p70 S6 kinase
(p70S6K, sc-8418) were purchased from Santa Cruz. Anti-CNOT1 (14276-1-AP)
was from Proteintech. Polyclonal anti-NUFIP2 (A301–600A) and anti-Roquin-1
(A300–514A) antibodies were obtained from BETHYL Laboratories. Anti-GFP (A-
6455) was from ThermoFisher. Anti-GAPDH (6C5) was from Calbiochem. Anti-
Fmrp (#4317), anti-Phosho-Stat3 (#9145) and anti-Phosho-Stat5 (#4322) were
obtained from Cell Signaling. Flow cytometry antibodies against human ICOS
(anti-CD278, clone ISA-3), mouse CD4 (Rm4-5), mouse CD62L (Mel-14), mouse
CD44 (IM-7), mouse Foxp3 (FJK-16s), and mouse ICOS (7E.17G9) were pur-
chased from eBioscience. Amine-reactive ﬂuorescent dyes Alexa Fluor® 488 Car-
boxylic Acid Succinimidyl Ester and Paciﬁc Blue™ Succinimidyl Ester were
obtained from Life Technologies. 4′ OH-tamoxifen, Doxycycline-Hyclat, and b-
isox were obtained from Sigma-Aldrich.
Transfection, transduction, and generation of stable cell lines. Retro- and
lentiviral supernatants were produced by calcium-phosphate transfection of
HEK293T as described previously11,15. For virus transduction, 100,000 MEF or
HeLa cells were plated onto each well of a six-well plate 18 h prior to transduction.
Infection with the desired amount of viral supernatant (100 μL to 2.5 mL) was
performed by centrifugation for 2 h at 32 °C, 300×g in the presence of 8 μg/mL
polybrene.
HeLa reporter cells were generated by co-transduction of HeLa cells with
plentiCMVtight Roquin-P2A-mCherry, the reverse transactivator (rtTA3), and
plenti PGK ICOS. Starting 48 h after transduction, cells were cultured in medium
supplemented with 500 μg/mL Geneticin (Neomycin) (Gibco), 2.85 μg/mL
Blasticidin S HCl (Gibco) and 500 μg/mL Hygromycin B (Invitrogen) for 7 days to
select for stably infected cells. A cell line with stable ICOS and dox-inducible co-
expression of Roquin and mCherry was obtained by single cell cloning. A stable
Rc3h1/2−/− MEF cell line allowing doxycycline-inducible co-expression of Roquin-
1 and mCherry was generated similarly by transduction with plentiCMVtight
Roquin-P2A-mCherry and the reverse transactivator (rtTA3). NUFIP2–deﬁcient
MEFs and HeLa cells were generated by transduction with lentiCRISPR vectors
encoding the respective NUFIP2-targeting sgRNAs together with Cas9. Starting 48
h after transduction, cells were cultured in the presence of 2 μg/mL puromycin
(Sigma) for 3 days to select for infected cells. After single cell cloning, the clone
showing the lowest NUFIP2 expression, as veriﬁed by immunoblotting, was chosen
as a stable NUFIP2 knockout cell line. Rc3h1/2−/− and Nuﬁp2−/− MEF cells with
doxycycline-inducible Roquin-1 overexpression were generated by co-transduction
with plentiCMVtight Roquin and the reverse transactivator (rtTA3) as described
above. Nuﬁp2-targeting sgRNAs (mNuﬁp2#4: 5′-GGCTTGTTTCTACAACTTGC-
3′, hNUFIP2: 5′-GCATGTTTCAGCGGCTTTGGC-3′) were designed with the
optimized CRISPR tool (http://crispr.mit.edu) provided by the Zhang lab and
cloned into the plentiCRISPR EFS GFP via BsmBI restriction sites. plentiCRISPR
EFS GFP was a kind gift from Dr. Benjamin Ebert (Addgene plasmid #57818)51
and provides stable expression of GFP, sgRNA, and Cas9 nuclease from one
vector.
Functional assays. Rc3h1/2−/− MEFs with doxycycline-inducible Roquin-1-P2A-
mCherry expression (described above) were employed for functional assays upon
retroviral transduction with different ICOS reporters. Starting 48 h after transduction,
cells were cultured in the presence of 1 μg/mL doxycycline to induce Roquin-1 and
mCherry expression. ICOS expression was quantiﬁed 48 h post-infection by ﬂow
cytometry as described previously3,11,15. Similarly, Rc3h1ﬂ/ﬂ; Rc3h2ﬂ/ﬂ; Cre-ERT2
MEF cells were transduced with different ICOS reporters by retroviral infection. For
in vitro deletion of Rc3h1 and Rc3h2, cells were cultured in the presence of 0.33 μM
4′-OH-tamoxifen for 4 days starting 48 h after transduction, followed by quantiﬁ-
cation of ICOS expression by ﬂow cytometry as described before.
For colocalization experiments, Rc3h1/2−/− MEF with doxycycline-inducible
Roquin-1 expression were transduced with GFP-Nuﬁp2 by retroviral infection.
Rc3h1/2−/− MEF cells lacking the cassette for doxycycline-inducible Roquin-1
expression were transduced with GFP-NUFIP2 for studying Nuﬁp2 localization in
the absence of endogenous Roquin expression.
Retroviral infection of Rc3h1ﬂ/ﬂ; Rc3h2ﬂ/ﬂ; Cd4-Cre-ERT2; rtTA CD4+ T cells
with pRetroXtight GFP-NUFIP2 was performed as described previously1. For
in vitro deletion of Rc3h1 and Rc3h2, T cells were treated with 1 μM 4′-OH-
tamoxifen for 24 h prior to activation.
Reverse transfection of HeLa cells with siRNAs was performed with the lipid-
based HiPerFect transfection reagent (Qiagen) according to the manufacturer’s
instructions.
For the analysis of mRNA stability transcription was stopped by addition of
actinomycin D (5 µg/mL) to the cell medium. Cells were harvested at different time
points after actinomycin D addition followed by total RNA isolation and reverse
transcription and quantitative PCR (RT-qPCR)-based determination of mRNA
amounts.
Super-resolution microscopy (3D-SIM). For ﬂuorescence microscopy, cells were
seeded onto coverslips and treated with 1 μg/mL of doxycycline for 14 h to induce
Roquin overexpression or left untreated. Before ﬁxation, cells were treated with 0.5
mM sodium arsenite (Sigma-Aldrich) for 1 h at 37 °C or left untreated. Cells were
ﬁxed with 2% formalin (ROTH) in PBS for 10 min and after a washing step in PBS
containing 0.02% Tween20 (PBST) cells were permeabilized in PBS containing
0.02% Tween20 (ROTH) and 0.5 % Triton X-100 (AppliChem) for 10 min. Cov-
erslips were treated with 2% bovine serum albumin (BSA) in TBST for 1–2 h at
room temperature. Subsequently, cells were stained with the primary antibodies
against Roquin (18F8), and either p70 S6 Kinase (1:1000 dilution) or G3bp1 (see
above) followed by a second antibody staining using anti-rat Alexa Fluor 594 (Life
Technologies) and anti-mouse CF405S (Biotium), respectively. GFP-NUFIP2 was
stained with GFP-Booster ATTO488 (ChromoTek), while endogenous Nuﬁp2 was
stained with a primary antibody against Nuﬁp2 (14G9) followed by a second
antibody staining using anti-rat Alexa Fluor 594 (Life Technologies). Primary
monoclonal antibody supernatants and the commercial G3bp1 antibody were
diluted 1:100, while the secondary antibodies anti-rat Alexa Fluor 594 and anti-
mouse CF405S were diluted 1:500 and 1:200, respectively. After a ﬁnal ﬁxation step
in 4% formalin (ROTH) in PBS the cells were mounted in Vectashield (Vector
Laboratories). Nuclei were stained with DAPI (Sigma-Aldrich). Images were
acquired with a DeltaVision OMX V3 microscope. 3D SIM raw data were
reconstructed and roughly corrected for color shifts with the software softWoRx
6.0 Beta 19 (unreleased). After establishing composite TIFF stacks with a custom-
made macro in Fiji, the data were subsequently aligned again.
Co-immunoprecipitation and immunoblotting. For preparation of the protein
lysates from CD4+ T cells, MEF, HeLa or HEK293T cells, cells were washed twice
with cold PBS and lysed in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.25% (v/v)
Nonidet-P40, 1.5 mM MgCl2, 1 mM dithiothreitol (DTT) supplemented with
EDTA-free protease inhibitor mix (Roche) for 20 min on ice. Lysates were cleared
by centrifugation at 10,000×g for 10 min at 4 °C and the protein concentration was
determined with the Bio Rad protein assay (Bradford assay). Equal amounts of
total protein (usually 50 μg protein/slot for detection of endogenous proteins) were
separated by SDS-PAGE, transferred to a nitrocellulose membrane and analyzed by
using primary antibodies (identiﬁed above) followed by horseradish peroxidase-
conjugated secondary antibodies. Primary monoclonal antibody supernatants were
diluted 1:10, while purchased antibodies were diluted according to the manu-
facturer’s protocol. Secondary species-speciﬁc antibodies were used in a 1:3000
dilution. For protein detection, the Amersham ECL Prime Western Blotting
Detection Reagent (GE Healthcare) and X-ray ﬁlms were used.
For immunoprecipitation, antibody-coupled beads were incubated with 2–5 mg
of protein lysate for 4 h at 4 °C in the presence or absence of RNAse (Roche). After
washing three times with lysis buffer the beads were resuspended in Laemmli SDS
sample buffer and boiled for 5 min at 95 °C for protein elution. The supernatant
was subjected to immunoblotting. For GFP-immunoprecipitation from
HEK293T cells (Fig. 5a, b), 5 µg polyclonal anti-GFP antibody was coupled to
Protein G Dynabeads (ThermoFisher Scientiﬁc). Pulldown of endogenous Roquin-
1/2 from MEF cells (Fig. 5c) was performed with anti-Roquin-1/2 (Q4-2)-coupled
tosylactivated MyOne Dynabeads (ThermoFisher Scientiﬁc). Antibody coupling
was performed according to the manufacturer’s instructions. Roquin-1 was
immunoprecipitated from HEK293T cells (Fig. 5e) with 4–5 µg polyclonal anti-
Roquin-1 antibodies coupled to Protein A Dynabeads (ThermoFisher Scientiﬁc).
Pulldown of endogenous NUFIP2 from HEK293T cells (Figs. 5d and 6c) was
performed with 1 mL monoclonal anti-Nuﬁp2 (23G8) supernatant coupled to
Protein G Dynabeads. Immunoblot analysis of Roquin-1 and Roquin-2 was
performed with monoclonal 3F12 antibody, while detection of Roquin-1 alone was
performed with polyclonal Roquin-1 antibodies. Immunoblot analysis of Nuﬁp2
expression was initially performed with the commercial polyclonal Nuﬁp2
antibody (Figs. 3c, d and 5a, b) and in all other experiments with the self-made
monoclonal antibody 23G8.
Pulldown of RNA-granule-like structures with b-isox was performed according
to Kato et al.35. Brieﬂy, MEF cells were lysed in 20 mM Tris buffer with 150 mM
NaCl, 5 mM MgCl2, 20 mM β-mercaptoethanol, 0.5% NP-40, 10% glycerol, EDTA-
free protease inhibitor cocktail (Roche), 0.1 mM phenylmethylsulfonyl ﬂuoride,
1:100 RNasin ribonuclease inhibitor (Promega, Madison, WI, USA), and 2 mM
vanadyl ribonucleoside vanadyl complex (NEB, Ipswich, MA, USA). Lysates were
incubated with 1–100 μM b-isox for 1 h at 4 °C on a rotating wheel. Reactions were
centrifuged for 15 min at 14,000×g, 4 °C, resulting in the separation of b-isox-
pelleted proteins and proteins in the supernatant. Supernatants were directly boiled
in Laemmli SDS sample buffer, while b-isox pellets were washed twice with lysis
buffer, resuspended in Laemmli buffer, boiled and loaded onto an SDS gel together
with the supernatants for protein analysis.
Quantitative RT-PCR. RNA was isolated from cells with TRI reagent® (Ambion)
or with the NucleoSpin® RNA Kit (Macherey-Nagel) according to the manu-
facturer’s instructions and reverse transcribed into cDNA with the QuantiTect®
Reverse Transcription Kit (Qiagen). Following reverse transcription, quantitative
PCR assays (qPCR) were run on a Light Cycler 480 II machine using the Roche
Universal Probe Library. Primers and universal probes are listed in Supplementary
Table 4. Relative gene expression was determined with the Light Cycler 480 SW
1.5.1 software, and normalized to the expression of the reference gene Ywhaz.
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High-throughput siRNA screen. High-throughput siRNA screening in HeLa cells
was performed by reverse transfection of siRNAs in 96-wells using the HiPerFect
transfection reagent (Qiagen). Forty microliters of the pre-diluted HiPerFect
transfection reagent were dispensed manually into each well of a 96-well U-bottom
plate (plate A) using a multichannel pipette. 8 μL of 1 mM siRNA library stocks
and 32 μL of H2O were subsequently added by a robot, and after mixing, the robot
dispensed half of the solution (40 μL) into a replicate plate (plate B). Eight
microliters of 1 mM control siRNAs in 32 μL H2O (siRoquin, siCtrl) had been
added manually before addition of the library stocks. Following an incubation time
of 10 min to allow complex formation, HeLa reporter cells were added in complete
DMEM medium to each well. Plates were incubated for 48 h and subsequently the
medium was replaced by fresh medium containing 1 μg/mL doxycycline. After 18 h
the cells were subjected to ﬂuorescent cell barcoding52,53 and antibody staining.
Fluorescent cell barcoding was in principal performed as described in ref. 52;
however, the protocol was adapted to label cell surface proteins only. HeLa cells
were washed once with PBS, trypsinized and transferred to U-bottom 96-well
plates. Washing steps were now carried out by resuspension, centrifugation at
400×g and 4 °C for 5 min followed by aspiration of the supernatant with a vacuum
pump containing an eight-channel adaptor. Cells were washed once with PBS,
while dilutions of the amine-reactive ﬂuorescent dyes Paciﬁc blue Succinimidyl
Ester and Alexa Fluor 488 Succinimidyl Ester were simultaneously prepared from
5mg/mL stock solutions in PBS. Four different barcoding solutions were generated
by employing both dyes in either a low (0.2 μg/mL) or a high (4 μg/mL) con-
centration. Cell pellets of each 96-well plate were resuspended in 50 μL of one of
the four distinct barcoding solutions, and plates were sealed, vortexed, and incu-
bated at 4 °C for 30 min. After washing twice with PBS+ 2% FCS, four plates with
differential barcoding signatures were pooled into one. After spinning for 5 min at
400xg, 4 °C, cells were subjected to antibody staining as described below and
analyzed by ﬂow cytometry.
Statistical analysis. ICOS mean ﬂuorescence intensity was determined with
FlowJo Version 10.2. Statistical analysis was performed with GraphPad Prism 5.0d,
and P-values were calculated with the Kruskal−Wallis test followed by Dunn’s
multiple comparison test. ICOS mRNA half-life values were calculated with
GraphPad Prism by one-phase decay.
The Z′ factor in pilot experiments was calculated according to Zhang et al.27. All
screen data were normalized into Z scores using the following equation:
Z ¼ ICOS MFIsampleICOS MFIplate averageSD plate
Flow cytometry. Antibody staining for ﬂow cytometry was performed as described
previously8,11,15. Brieﬂy, cells were subjected to a 1:200 dilution of primary anti-
bodies for 20 min at 4 °C, washed with PBS +2% FCS (FACS buffer) and subjected
to a secondary antibody staining if necessary. After two ﬁnal washing steps, cells
were resuspended in 100 μL FACS buffer and acquired on a LSR II Fortessa cell
analyzer (BD Bioscience).
Sequence and structure conservation analysis. All mRNA and sequence data
used in this study were acquired from the NCBI Reference Sequence Database
(RefSeq) collection release 6954. A data set was prepared by extracting all mRNAs
of ICOS. Only mRNAs with a completely annotated 3′-UTR were used. The data
set included 24 mammals. A complete list of species and associated identiﬁcation
numbers used in this study is given as Supplementary Table 5.
A combined multiple sequence-structure alignment of the data set sequences
were obtained applying LocARNA version 1.8.139 with the option local-progressive
followed by RNAalifold55 from the ViennaRNA package version 2.1.8-256.
Data availability. The data sets generated during and/or analyzed during the
current study are available from the corresponding author on reasonable request.
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